<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>MOLGENIS</title>
        <description>MOLGENIS is an open-source platform for FAIR scientific data management in genomics, biobanking, and rare disease research.</description>
        <link>https://www.molgenis.org/</link>
        <atom:link href="https://www.molgenis.org/feed.xml" rel="self" type="application/rss+xml"/>
        <pubDate>Thu, 24 Sep 2026 10:13:53 +0000</pubDate>
        <lastBuildDate>Thu, 24 Sep 2026 10:13:53 +0000</lastBuildDate>
        <generator>Jekyll v3.10.0</generator>
        
        <item>
            <title>MOLGENIS listed as NWO Large Scale Research Infrastructure</title>
            <description>
                
                &lt;p&gt;MOLGENIS has been listed as NWO Large-Scale Research Infrastructure by the NWO.&lt;/p&gt;

&lt;p&gt;Large-scale Research Infrastructures (LSRI) are facilities, resources, and services that enable research communities to carry out research and stimulate cutting-edge work in their field. Where relevant, these infrastructures can also be used for purposes beyond research, such as education or public services.&lt;/p&gt;

&lt;p&gt;Large-scale research infrastructures comprise: the relevant human resources; major equipment or collections of instruments; knowledge-related facilities such as collections, archives or scientific data infrastructures; computing systems and communication networks; and any other unique infrastructure that is open to external users and essential for achieving excellence in research and innovation. Research infrastructures may be located at a single site, distributed across multiple sites, or be virtual, either within the Netherlands or internationally.&lt;/p&gt;

&lt;p&gt;A large-scale research infrastructure must promote an open access policy for research. This means that the infrastructure provides access to researchers from outside the hosting organisation(s), based on scientific excellence. The term ‘research’ covers the full spectrum of scientific activity, from fundamental to applied research.&lt;/p&gt;

&lt;div&gt;
&lt;img src=&quot;/assets/img/logo-gwi-blue.png&quot; alt=&quot;GWI logo blue&quot; style=&quot;max-width: 60%&quot; /&gt;
&lt;/div&gt;

&lt;p&gt;&lt;a href=&quot;https://www.onderzoeksfaciliteiten.nl/en/facilities/molgenis&quot;&gt;Visit our facility page&lt;/a&gt;
&lt;br /&gt;
&lt;a href=&quot;https://www.onderzoeksfaciliteiten.nl/en/definition-large-scale-research-infrastructure-lsri&quot;&gt;More info about Large-Scale Research Infrastructures&lt;/a&gt;&lt;/p&gt;

                
            </description>
            <pubDate>Thu, 24 Sep 2026 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/news/2026/09/24/molgenis-gwi.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/news/2026/09/24/molgenis-gwi.html</guid>
            
            
            <category>news</category>
            
        </item>
        
        <item>
            <title>Accelerating rare disease diagnostics by linking DNA and RNA through an explainable and interactive RNA-guided workflow</title>
            <description>
                
                Read all about it in <a href="https://academic.oup.com/nargab/article/8/1/lqag016/8472097?login=false">Willem T.K. Maassen et al (2025) Accelerating rare disease diagnostics by linking DNA and RNA through an explainable and interactive RNA-guided workflow</a>
                
            </description>
            <pubDate>Mon, 13 Jul 2026 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2026/07/13/accelerating-rare-disease-diagnostics.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2026/07/13/accelerating-rare-disease-diagnostics.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>A multidisciplinary RNA-guided approach to complement genomic analysis of unsolved patients with an inborn error of immunity</title>
            <description>
                
                Read all about it in <a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1829883/full">Willem T.K. Maassen et al (2025) A multidisciplinary RNA-guided approach to complement genomic analysis of unsolved patients with an inborn error of immunity</a>
                
            </description>
            <pubDate>Mon, 13 Jul 2026 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2026/07/13/a-multidisciplinary-rna-guided-approach.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2026/07/13/a-multidisciplinary-rna-guided-approach.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>National Undiagnosed Hackathon at Radboudumc</title>
            <description>
                
                &lt;p&gt;Several of our colleagues recently took part in the first National Undiagnosed Hackathon at Radboudumc, where 140 specialists from all Dutch university medical centers joined forces to help patients with rare, undiagnosed conditions. Over the course of 48 hours, multidisciplinary teams of clinicians, researchers, bioinformaticians and data analysts worked intensively on 33 complex patient cases in the hope of finding long-awaited diagnoses.&lt;/p&gt;

&lt;p&gt;The event highlighted the power of collaboration and innovation in rare disease diagnostics. With more than 7,000 known rare diseases worldwide, patients often face years of uncertainty before receiving a diagnosis. By combining expertise, advanced genetic analysis and fresh perspectives, the hackathon aimed to accelerate answers for patients and their families.&lt;/p&gt;

&lt;p&gt;We are proud that our colleagues contributed to this important initiative and to the shared effort of improving care and outcomes for people living with rare diseases.&lt;/p&gt;

&lt;div&gt;
&lt;img src=&quot;/images/posts/hackathon1.jpg&quot; alt=&quot;Hackathon 1&quot; style=&quot;max-width: 30%; float:left; margin-right: 20px;&quot; /&gt;
&lt;img src=&quot;/images/posts/hackathon2.jpg&quot; alt=&quot;Hackathon 2&quot; style=&quot;max-width: 60%&quot; /&gt;
&lt;/div&gt;

&lt;p&gt;&lt;a href=&quot;https://www.radboudumc.nl/nieuws/2026/specialisten-uit-alle-umcs-48-uur-bijeen-op-zoek-naar-diagnoses-voor-33-zeldzame-aandoeningen&quot;&gt;More info here&lt;/a&gt;&lt;/p&gt;

                
            </description>
            <pubDate>Fri, 22 May 2026 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/news/2026/05/22/undiagnosed-hackathon.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/news/2026/05/22/undiagnosed-hackathon.html</guid>
            
            
            <category>news</category>
            
        </item>
        
        <item>
            <title>Variant Interpretation Pipeline (VIP) highlighted by Oxford Nanopore Technologies</title>
            <description>
                
                Read all about it in <a href="https://www.mdpi.com/1422-0067/26/7/2850">De Boer et al (2025) Nanopore Long-Read Sequencing as a First-Tier Diagnostic Test to Detect Repeat Expansions in Neurological Disorders</a>
                
            </description>
            <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2026/04/23/vip-oxford-nanopore.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2026/04/23/vip-oxford-nanopore.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>Another successfull roll-out of MOLGENIS Armadillo DataSHIELD network from our partner IPEC, with the focus on predicting psychosis.</title>
            <description>
                
                Read all about it in <a href="https://doi.org/10.1093/schbul/sbaf094">Brink et al (2025) The International Psychosis Epidemiology Consortium Virtual Databank—A Platform for Data Harmonization and Federated Analysis of Psychosis Cohorts. Schizophrenia Bulletin.</a>
                
            </description>
            <pubDate>Thu, 17 Jul 2025 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2025/07/17/brink.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2025/07/17/brink.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>Publication of MOLGENIS Variation Interpretation Pipeline (VIP).</title>
            <description>
                
                Read all about it in <a href="https://doi.org/10.1093/nargab/lqaf087">Maassen et al. (2025) MOLGENIS VIP: an end-to-end DNA variant interpretation pipeline for research and diagnostics configurable to support rapid implementation of new methods. NAR Genomics and Bioinformatics.</a>
                
            </description>
            <pubDate>Mon, 23 Jun 2025 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2025/06/23/vip.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2025/06/23/vip.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>Showcasing data harmonization and federated analysis in the EUCAN-connect project</title>
            <description>
                
                Read all about it in <a href="https://doi.org/10.1007/s10654-024-01126-4">Bergeron et al (2024) Stress and anxiety during pregnancy and length of gestation: a federated study using data from five Canadian and European birth cohorts. Eur J Epidemiol.</a>
                
            </description>
            <pubDate>Wed, 28 May 2025 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2025/05/28/bergeron.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2025/05/28/bergeron.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>Using MOLGENIS DataSHIELD to analyse 107,884 mother-child dyads from 7 European birth cohorts across 6 countries highlighting consistent tendency for children from disadvantaged SECs to be at greater risk of asthma.</title>
            <description>
                
                Read all about it in <a href="https://doi.org/10.1016/j.jaip.2025.02.032">Pinot de Moira et al (2025) Understanding Social Inequalities in Childhood Asthma: Quantifying the Mediating Role of Modifiable Early-Life Risk Factors in Seven European Birth Cohorts.  Allergy Clin Immunol Pract.</a>
                
            </description>
            <pubDate>Thu, 01 May 2025 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2025/05/01/pinot.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2025/05/01/pinot.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
        <item>
            <title>VIP pipeline helped to produce first results using novel nanopore sequencing!</title>
            <description>
                
                Read all about it in <a href="https://doi.org/10.3390/ijms26072850">de Boer et al (2025) Nanopore Long-Read Sequencing as a First-Tier Diagnostic Test to Detect Repeat Expansions in Neurological Disorders. Int.J.Mol. Sci</a>
                
            </description>
            <pubDate>Tue, 25 Mar 2025 00:00:00 +0000</pubDate>
            <link>https://www.molgenis.org/publication/2025/03/25/nanopore.html</link>
            <guid isPermaLink="true">https://www.molgenis.org/publication/2025/03/25/nanopore.html</guid>
            
            
            <category>publication</category>
            
        </item>
        
    </channel>
</rss>